Diversified Trust’s Janux Therapeutics JANX Stock Holding History

Diversified Trust’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Buy	+16,841	New	+$244K	﹤0.01%	965

Other funds holding JANX

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Aventura Private Wealth Aventura, Florida $326M AUM 34.36% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Ares Financial Consulting Calabasas, California $139M AUM

Diversified Trust's JANX Position: Q2 2026 in Review

Diversified Trust opened a new position in Janux Therapeutics (JANX) in Q2 2026: 16,841 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #965 among its holdings.

12 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Diversified Trust held 16,841 shares of Janux Therapeutics worth $259K as of Q2 2026.
Janux Therapeutics was a new Diversified Trust position in Q2 2026.
Janux Therapeutics made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #965 holding.
12 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.